x
0
SCOTTRADE ACCOUNT IT'S TIME. It's time for an easier way to invest. Open a Scottrade Account
Apply Now

Regeneron Pharmaceuticals Inc (REGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Regeneron Pharma's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
373.00 +7.98    +2.19%
24/03 - Closed. Currency in USD ( Disclaimer )
After Hours
373.00
0.00
0.00%
21:56:38 GMT - Real-time Data
Type: Equity
Market: United States
ISIN: US75886F1075 
CUSIP: 75886F107
  • Volume: 881,363
  • Bid/Ask: 370.25 / 373.00
  • Day's Range: 366.72 - 374.85
START TRADING NOW
Regeneron Pharma 373.00 +7.98 +2.19%

REGN Overview

 
Information about the Regeneron Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close365.02
Day's Range366.72 - 374.85
Revenue4.86B
Open367.92
52 wk Range325.35 - 452.96
EPS7.71
Volume881,363
Market Cap39.57B
Dividend (Yield)0 (N/A)
Average Vol. (3m)767,094
P/E Ratio48.38
Beta1.35
1-Year Change0.59%
Shares Outstanding106,080,755
Next Earnings DateMay 03, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Buy Buy Neutral Sell Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Sell Strong Sell
Summary Strong Buy Strong Buy Buy Strong Sell Neutral

Candlestick Patterns

Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Inside Up 1H Current
Completed Patterns
Three Inside Up 5H 1 Mar 24, 2017 10:00AM
Bullish Engulfing 15 1 Mar 24, 2017 03:30PM
Three Outside Down 1H 2 Mar 24, 2017 01:00PM

Regeneron Pharmaceuticals Inc News & Analysis

Regeneron Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 373.00 370.25 373.00 881,363 +2.19% USD 24/03  
  Switzerland 395.60 0.00 0.00 0 0.00% CHF 16/12  
  Berlin 340.14 0.00 0.00 0 -0.92% EUR 24/03  
  Munich 340.54 0.00 0.00 0 -0.77% EUR 24/03  
  Stuttgart 343.61 0.00 0.00 255 +1.30% EUR 24/03  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 140.64 141.74 140.35 -0.28 -0.20% 22.40M 24/03  
  Facebook 140.34 141.02 139.76 +0.81 +0.58% 16.66M 24/03  
  Snap Inc 22.74 23.10 22.34 -0.39 -1.69% 17.26M 24/03  
  Micron 28.43 29.87 28.16 +1.96 +7.40% 107.48M 24/03  
  Tesla 263.16 263.89 255.01 +8.38 +3.29% 5.65M 24/03  
  SBI 275.95 278.95 268.65 +7.45 +2.77% 20.08M 24/03  
  Pak Datacom Ltd 61.00 61.00 59.01 +1.83 +3.09% 7.00K 24/03  
  AMD 13.700 14.180 13.540 -0.090 -0.65% 50.10M 24/03  
  Bank Of Baroda 168.30 171.55 162.00 +6.10 +3.76% 23.24M 24/03  
  HTG Molecular Diagnostics 9.650 13.250 5.970 +5.720 +145.55% 53.73M 24/03  

Regeneron Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

5400

Equity Type

ORD

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), National Securities Depository (India), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $2000 Start Trading
Securities and Exchange Commission (United States) $2500 Start Trading
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest REGN Comments

Theodoridis Thomas
Theodoridis Thomas Nov 12, 2015 5:43PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its coming and its from the weekly graph. From the serious investors. I don`t bear any responsibility for any trading losses you might incur as a result of using this data .
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.